Inhibikase Therapeutics, Inc.
IKT
NASDAQ1.65
USD
+0.00
- -
Inhibikase Therapeutics, Inc. (IKT) Stock Split History
The latest split
Jun 30, 2023
1:6
For every 6 shares held, investors received 1. The price per share adjusted from $0.60 to $0.10.
The split itself did not change the total investment value.
Use this split data in your app
Build with our dataA history of stock splits
- Jun 30, 2023Before$0.60Split ratio1:6After$0.10Reverse
About Inhibikase Therapeutics, Inc. stock splits
Inhibikase Therapeutics, Inc. (IKT) trades on the NASDAQ in the Biotechnology industry.
Inhibikase Therapeutics, Inc. company overviewWhen was Inhibikase Therapeutics, Inc.'s latest recorded stock split?
The latest split shown was on June 30, 2023. It was a 1-for-6 reverse split, so shareholders received 1 share for every 6 they held.
How many stock splits are recorded for Inhibikase Therapeutics, Inc.?
This history records one reverse split, on June 30, 2023.